| Literature DB >> 29487869 |
Yoo Jung Park1, Sun Wook Park1, Han Suk Lee2.
Abstract
OBJECTIVES: The goals of this study were to assess the effectiveness of WBV (whole body vibration) training through an analysis of effect sizes, identify advantages of WBV training, and suggest other effective treatment methods.Entities:
Mesh:
Year: 2018 PMID: 29487869 PMCID: PMC5816889 DOI: 10.1155/2018/5083634
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flow diagram of studies included.
Characteristic of included trials.
| Study | Number of participants analyzed ( | Mean age ( | Start REH intervention ( | Duration of prog. | Time |
|---|---|---|---|---|---|
| Brogardh et al. 2012 [ | 16/15 | 61.3 ± 8.5/63.9 ± 5.8 | 37.4/33.1 m | 2/week | 45 min |
| Chan et al. 2012 [ | 15/15 | 56.07 ± 11.04/54.93 ± 7.45 | 30.4/38.87 m | One session | |
| Choi et al. 2014 [ | 15/15 | 62.8 ± 9/65.1 ± 15.7 | 13/12.6 | 5/w | 15 min |
| Lau et al. 2012 [ | 41/41 | 57.3 ± 11.3/57.4 ± 11.1 | 4.6/5.3 y | 3/w | |
| Liao et al. 2016 [ | 28/28 | 59.8 ± 9.1/60.8 ± 8.3 | 8.5/9.0 y | 3/w | 12 min |
| Marin et al. 2013 [ | 11/9 | 62.3 ± 10.6/64.4 ± 7.6 | 4.3/4.3 y | 12 w (17 sessions) | |
| Pang et al. 2013 [ | 38/38 | 57.3 ± 11.3/57.4 ± 11.1 | 4.6/5.3 y | 3/w | |
| Tankisheva et al. 2014 [ | 6/7 | 57.4 ± 13/65.3 ± 3.7 | 7.71/5.28 y | 3/w | 30 min |
| Tihanyi et al. 2007 [ | 8/8 | 58.2 ± 9.4 | 27.2 ± 10.4 d | One session | |
| van Nes et al. 2006 [ | 27/26 | 59.7 ± 12.3/62.6 ± 7.6 | 38.9/34.2 d | 5/w | |
| Yule et al. 2016 [ | 4/2 | 50.5 ± 14.5/39 ± 2 | 6 m–5 y | 3/w | 15 min |
Review of the studies.
| Study | Outcome measures | Type of intervention | control | frequency | amplitude |
|---|---|---|---|---|---|
| Brogardh et al. 2012 [ | Muscle tone: MAS | Standing barefoot on the platforms in a static position with the knee flexed 45° 60° | vibrating platform | 25 | 3.75 |
|
| |||||
| Chan et al. 2012 [ | Ankle spasticity: | Positioned on the platform in a semisquatting position with buttock support and were kept in an upright position with even weight distribution on both feet | same procedure, No WBV | 12 | 4 |
|
| |||||
| Choi et al. 2014 [ | Static sitting balance: COP | Task oriented training + WBV | task oriented training | 15–22 | 0–5.8 |
|
| |||||
| Lau et al. 2012 [ | Balance: BBS | Side-to-side weight shift, semisquat, forward and backward weight shift, forward lunge, standing on one leg, deep squat | same platform, No WBV | 20–30 | 0.44–0.6 |
|
| |||||
| Liao et al. 2016 [ | Muscle tone: MAS | Dynamic weight shift side to side, dynamic deep squat, | same platform, No WBV | 20 | 1 |
|
| |||||
| Marin et al. 2013 [ | Balance: BBS | Standing on a vibration platform with knee flexion of 30° | same position, No WBV | 5–21 | 4–6 |
|
| |||||
| Pang et al. 2013 [ | Bone turnover markers | Side-to-side weight shift, semisquat, forward and backward, weight shift, forward lunge, standing on one leg, deep squat | same platform, No WBV | 20–30 | 0.44–0.6 |
|
| |||||
| Tankisheva et al. 2014 [ | Muscle tone: MAS | Standing on their toes, knee flexion of 50–60, knee flexion of 90°, wide-stance squat, one-legged squat | No | 35, 40 | 1.7, 2, 5 |
|
| |||||
| Tihanyi et al. 2007 [ | EMG: | Standing the platform with knees slightly flexed at 40° and shifting body mass to the paretic leg | same platform, No WBV | 20 | 5 |
|
| |||||
| van Nes et al. 2006 [ | Balance: BBS | Standing on the platform with knees slightly flexed | Exercise therapy on music | 30 | |
|
| |||||
| Yule et al. 2016 [ | Pulse wave velocity | Static squat stance with 70° knee flexion | No | 22–26 | |
MAS: Modified Ashworth Scale, BBS: Berg Balance Scale, TUG: Timed Up & Go, SIS: Stroke Impact Scale, 10 MGS: 10 miters' gait speed, 6 MWT: six-minute walk test, COP: Center of Pressure; MFRT: Modified Functional Reach Test, LOS: Limit of Stability, 10 MWT: 10 miters' walk test, ABC: activities-specific balance confidence scale.
Quality assessment.
| Brogardh et al. (2012) | Chan et al. (2012) | Choi et al. (2014) | Lau et al. (2012) | Liao et al. (2016) | Marin et al. (2013) | Pang et al. (2013) | Tankisheva et al. (2014) | Tihanyi et al. (2007) | van Nes et al. (2006) | Yule et al. (2016) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Eligibility criteria | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
| Random allocation | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
| Concealed allocation | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
| Baseline comparability | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
| Blinded subjects | Yes | Yes | No | No | No | No | No | No | No | No | Not Yet |
| Blinded therapists | Yes | No | No | No | No | No | No | No | No | No | Not Yet |
| Blinded assessors | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | No | Yes | Not Yet |
| Adequate follow-up | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
| Intention-to-treat analysis | Yes | No | Yes | Yes | Yes | Yes | Yes | No | No | Yes | Not Yet |
| Between-group comparisons | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
| Point estimators and variability | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not Yet |
| Total PEDro score | 9 | 8 | 6 | 8 | 8 | 8 | 8 | 7 | 6 | 8 | Not Yet |
| Sample size ≥ 50 | No | No | No | Yes | No | No | Yes | No | Yes | Yes | No |
| Level of evidence | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 2 |
Homogeneity test and the total effect size.
|
|
|
|
| Point estimate | 95% CI | Standard error |
|---|---|---|---|---|---|---|
| 11 | 18.02 | 0.00 | 44.5 | 0.25 | 0.17–0.32 | 0.04 |
Figure 2Homogeneity test.
Trim-and-fill publication bias assessment.
| Studies trimmed | Point estimate | 95% CI |
| ||
|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||
| Observed values | - | 0.25 | 0.17 | 0.32 | 18.02 |
| Adjusted values | 0 | 0.25 | 0.1 | 0.32 | 18.02 |
Effect size according to treatment effectiveness.
| Group | Number of studies | Point estimate | Standard error | 95% CI |
|---|---|---|---|---|
| Balance | 19 | 0.28 | 0.08 | 0.12–0.43 |
| Muscle strength | 40 | 0.16 | 0.05 | 0.07–0.25 |
| Gait function | 15 | 0.09 | 0.07 | −0.06–0.24 |
| Spasticity | 3 | 1.24 | 0.23 | 0.76–1.7 |
| Bone metabolism | 2 | 0.99 | 0.18 | 0.65–1.35 |
| Cardiac function | 3 | 0.2 | 0.4 | −0.59–0.99 |
|
| ||||
| Total | 82 | 0.22 | 0.04 | 0.16–0.29 |
Figure 3Effect size at different vibration frequencies.
Figure 4Effect size according to the time lapse after the onset of stroke.
Figure 5Effect size according to the treatment period.
Figure 6Effect size according to the number of treatments per week.
Figure 7Changes per published year.